Compound Profile

Arjunolic Acid

Pentacyclic triterpenoid from Terminalia arjuna bark with cardioprotective and antioxidant properties.

Use extra caution Mostly preclinical or extract derived; concentrated doses may affect glucose, lipids, liver enzymes, or bleeding risk depending matrix. Details

Last reviewed: Report a correctionProfile-wide ·C Limited
Arjunolic Acid monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Mostly preclinical or extract-derived; concentrated doses may affect glucose, lipids, liver enzymes, or bleeding risk depending matrix.
Profile context
NF-κB, AMPK, PPAR
Next steps

Continue reading

Quick stats

Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
NF κB, AMPK, PPAR
Avoid / review if
Liver

Botanical Context

Source botanicals and comparison guides related to Arjunolic Acid.

Safety

Safety & Cautions

Mostly preclinical or extract derived; concentrated doses may affect glucose, lipids, liver enzymes, or bleeding risk depending matrix.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Evidence Summary

Profile-wide ·C Limited

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedImmune Signaling Modulation · Lipid Profile/Endothelial Support · Metabolic Regulation

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableMostly preclinical or extract derived; concentrated doses may affect glucose, lipids, liver enzymes, or bleeding risk depending matrix.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Limited evidence

Arjunolic Acid has a limited evidence rating.

AdaptogenStress & MoodLongevity
Effects
5
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How Arjunolic Acid Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Arjunolic Acid Works

How Arjunolic Acid WorksArjunolic Acid acts on biological target pathways via anti inflammatory, leading to nf κb.Arjunolic AcidBiological TargetBiological pathwayAnti InflammatoryNf κBObservable outcomeMetabolicRegulation
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

No standardized dose
standardized extract or essential oil free preparation when oral use is intended
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Immune Signaling Modulation
  • Lipid Profile/Endothelial Support
  • Metabolic Regulation
  • Mitochondrial Function Support
  • AMPK Signaling
  • Anti Inflammatory Signaling Modulation

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Arjunolic Acid evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?